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Lijing Xina*, Giulio Gambarotaa, Joa˜o M. N. Duarteb, Vladimı´r Mlyna´rika
and Rolf Gruettera,b,cThe medulla oblongata (MO) contains a high densityNMR Biomof glycinergic synapses and a particularly high concentration of
glycine. The aims of this study were to measure directly in vivo the neurochemical profile, including glycine, in MO
using a spin-echo-based 1H MRS sequence at TE¼ 2.8 ms and to compare it with three other brain regions (cortex,
striatum and hippocampus) in the rat. Glycine was quantified in MO at TE¼ 2.8 ms with a Crame´r–Rao lower bound
(CRLB) of approximately 5%. As a result of the relatively low level of glycine in the other three regions, the
measurement of glycine was performed at TE¼ 20 ms, which provides a favorable J-modulation of overlapping
myo-inositol resonance. The other 14 metabolites composing the neurochemical profile were quantified in vivo in
MO with CRLBs below 25%. Absolute concentrations of metabolites in MO, such as glutamate, glutamine,
g-aminobutyrate, taurine and glycine, were in the range of previous in vitro quantifications in tissue extracts.
Compared with the other regions, MO had a three-fold higher glycine concentration, and was characterised by
reduced (p< 0.001) concentrations of glutamate (S50W 4%), glutamine (–54W 3%) and taurine (S78W 3%). This
study suggests that the functional specialisation of distinct brain regions is reflected in the neurochemical profile.
Copyright  2010 John Wiley & Sons, Ltd.
Keywords: glycine; neurochemical profile; medulla oblongata; NMR spectroscopy* Correspondence to: L. Xin, Lijing Xin, Ecole Polytechnique Fe´de´rale de Lau-
sanne (EPFL), SB-IPSB-LIFMET, CH F1 633, Station 6, CH-1015 Lausanne,
Switzerland.
E-mail: lijing.xin@epfl.ch
a L. Xin, G. Gambarota, V. Mlyna´rik, R. Gruetter
Laboratory of Functional and Metabolic Imaging (LIFMET), Ecole Polytechni-
que Fe´de´rale de Lausanne, Lausanne, Switzerland
b J. M. N. Duarte, R. Gruetter
Department of Radiology, University of Lausanne, Lausanne, Switzerland
c R. Gruetter
Department of Radiology, University of Geneva, Geneva, Switzerland
Contract/grant sponsors: Centre d’Imagerie BioMe´dicale (CIBM) of University
of Lausanne (UNIL), University of Geneva (UNIGE), Hoˆpitaux Universitaires de
Gene`ve (HUG), Centre Hospitalier Universitaire Vaudois (CHUV), Ecole Poly-
technique Federale de Lausanne (EPFL); Leenaards and Jeantet Foundations.
Abbreviations used: Ala, alanine; ANOVA, analysis of variance; Asc, ascor-
bate; Asp, aspartate; BHB, b-hydroxybutyrate; CO, cortex; Cr, creatine; CRLB,
Crame´r–Rao lower bound; FAST(EST)MAP, fast, automatic shim technique
using echo-planar signal readout for mapping along projections; FID, free
induction decay; GABA, g-aminobutyrate; Glc, glucose; Gln, glutamine; Glu,
glutamate; Gly, glycine; GPC, glycerophosphocholine; GSH, glutathione; HI,
hippocampus; Ins, myo-inositol; Lac, lactate; MO, medulla oblongata; NAA,
N-acetylaspartate; NAAG, N-acetylaspartylglutamate; NT, number of transi-
ents; PCho, phosphocholine; PCr, phosphocreatine; PE, phosphoethanolamine;
Scyllo, scyllo-inositol; SEM, standard error of the mean; SNR, signal-to-noise
ratio; SPECIAL, spin-echo, full-intensity acquired localised; ST, striatum; Tau,
taurine; tCr, total creatine; VAPOR, variable power radiofrequency pulses with
optimised relaxation delays; VOI, volume of interest. 1INTRODUCTION
The medulla oblongata (MO) is a part of the brainstem that
regulates motor and sensory functions, as well as autonomic
processes, such as heart beat, breathing and blood pressure. InMO,
glycine (Gly) is present at a particularly high concentration. Gly
has a dual role as an inhibitory neurotransmitter, activating Gly
receptors, and as a co-agonist for excitatory N-methyl-D-
aspartate receptors (1). In addition to its roles in neurotrans-
mission and neuromodulation, Gly is the precursor of
metabolites such as purines, creatine (Cr) and glutathione
(GSH), and may be incorporated in lipids and proteins (2). The
enhancement of Gly release in the brainstem has been
proposed to be a neuroprotectivemechanism against metabolic
noxious stimuli, such as hypoxia, hypoglycaemia and ischaemia
(3). In addition, lesions of MO are involved in several
pathologies, such as hypertension (4) and multiple sclerosis
(5). Therefore, it is of interest to investigate in vivo MO, with a
specific focus on Gly tissue levels.
Localised MRS, as a noninvasive technique of exploring
neurochemical information (6,7), is a desirable choice for the
in vivo measurement of the neurochemical profile, including Gly
inMO. As Gly is present at low concentrations in the forebrain and
its resonance signal overlaps with the larger resonance of
myo-inositol (Ins) in the 1H MR spectrum, in vivo detection of Gly
by MRS is challenging. In a number of studies, Gly tissue levels
have been measured in human brain (8,9). Recently, the direct
detection of Gly in rat brain in vivo has been reported, using
spin-echo excitation at TE¼ 20 ms (10). To our knowledge, in vivoed. 2010; 23: 1097–1102 Copyright  2010 John Wiley & Sons, Ltd.
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has not been reported to date.
In this study, we hypothesised that the combination of short-TE
spin-echo excitation localisation and highmagnetic field strength
(9.4 T) would provide a high spectral resolution and signal-
to-noise ratio (SNR), which would, in turn, allow a thorough
investigation of the neurochemical profile of the medulla.
Therefore, the aims of this investigation were to measure in vivo
the neurochemical profile of rat MO by localised 1H NMR
spectroscopy, with particular focus on Gly quantification at
TE¼ 2.8 ms, and to compare the neurochemical profile of MO
with that of the hippocampus (HI), striatum (ST) and cortex (CO).METHODS
Animal preparation
Experiments were performed on Sprague Dawley rats
(274 16 g, n¼ 6) under isoflurane anaesthesia (1.5–2% in
oxygen). The animals were placed in a homebuilt holder, and
the head was fixed by a bite bar and a pair of ear bars. The
respiration rate was monitored by a small animal monitor (SA
Instruments Inc., Stony Brook, NY, USA) and the body temperature
was measured by a rectal thermosensor and maintained at
38.0 0.58C by circulating heated water. All animal procedures
were performed according to federal guidelines and were
approved by the local ethics committee.
MRS
Proton NMR experiments were performed on a Varian INOVA
console (Varian, Palo Alto, CA, USA) interfaced to an actively
shielded 9.4 T/31 cm magnet (Magnex Scientific, Abingdon,
Oxfordshire, UK) with a 12 cm inner diameter, actively shielded
gradient (400 mT/m in 120 ms). A homebuilt geometrically
decoupled 1H quadrature surface coil (17mm in diameter) was
used as transceiver. Fast automatic shimming employing the fast,
automatic shim technique using echo-planar signal readout for
mapping along projections [FAST(EST)MAP] (11) was used to
adjust all first- and second-order shims.
In vivo proton spectra were acquired using the spin-echo,
full-intensity acquired localised (SPECIAL) spectroscopy method,
which consists of a 2 ms slice-selective full-passage adiabatic
pulse (hyperbolic secant 10) with a bandwidth of 10 kHz (gB1/
2p¼ 3.7 kHz) applied on alternate scans, followed by a spin-echo
sequence [0.5 ms/908 and 1 ms/1808 asymmetric slice-selective
pulses with bandwidths of 13.5 kHz, gB1/2p¼ 3.35 kHz and
6.2 kHz, gB1/2p¼ 4.95 kHz, respectively (12)]. Two TEs, i.e. 2.8 and
20ms, were used for the assessment of the neurochemical profile
in all four cerebral regions and for the Gly measurement in CO, HI
and ST, respectively. Water suppression was achieved using
variable power radiofrequency pulses with optimised relaxation
delays (VAPOR) (13) and three outer volume saturation modules
were interleaved with water suppression elements (13). Volumes
of interest (VOIs) of 4 2 4, 6 1.5 2, 3 2.5 2 and
3 2 2mm3 were located in MO, CO, ST and HI, respectively.
The surface coil was shifted to the posterior part of the head for
the measurement of MO. Images of rat brain acquired with a fast
spin-echo sequence (matrix, 128 128; TE¼ 40 ms; echo train
length, 8; TR¼ 4 s; slice thickness, 1mm; 13 slices; 4 averages)
were used for the positioning of the VOIs. Flip angles in SPECIAL
were adjusted for each VOI. All spectra were acquired with theView this article online at wileyonlinelibrary.com Copyrigfollowing acquisition parameters: spectral width, 5 kHz; 4096
complex data points; TR¼ 4 s. The acquisition at each TE
consisted of an array of free induction decays (FIDs) (16 averages
for each FID) that were saved separately [CO: number of
transients (NT), 240; HI: NT¼ 240–480; ST: NT¼ 480–640; MO:
NT¼ 800–960). Spectra acquired without water suppression at
the corresponding TE were used as internal reference for the
quantification of metabolite concentrations. B0 shift correction
was performed prior to summation of the spectra, and eddy
current effects were corrected with the acquired reference water
signal.
Data analysis
Spectral data analysis was performed with LCModel (14), using a
basis set containing simulated metabolite spectra and a
macromolecular baseline measured by the inversion recovery
method (15). As a result of the use of short TE, the effect of an
inhomogeneous B1 within the voxel (approximately 15–30%
variation) on the evolution of J-coupled resonances, reported by
Snyder et al. (16), was considered to be negligible. Therefore,
nominal flip angles were used in the simulation of the spectra. For
the quantification of short-TE spectra (TE¼ 2.8 ms), the
unsuppressed water signal was used as an internal reference.
Regional water content differences were taken into account
when assessing the metabolite quantification (17). The Gly
concentration in CO, HI and ST was obtained from spectra
acquired at TE¼ 20 ms using the regional total creatine (tCr)
concentration obtained at TE¼ 2.8 ms as the internal reference,
assuming similar T2 relaxation at 9.4 T (18). The spectral basis sets
included the following metabolites: alanine (Ala); lactate (Lac);
g-aminobutyrate (GABA); N-acetylaspartate (NAA); glutamate
(Glu); glutamine (Gln); aspartate (Asp); Cr; phosphocreatine (PCr);
glycerophosphocholine (GPC); taurine (Tau); Ins; Gly; GSH;
phosphocholine (PCho); ascorbate (Asc); scyllo-inositol (Scyllo);
N-acetylaspartylglutamate (NAAG); b-hydroxybutyrate (BHB);
glucose (Glc); phosphoethanolamine (PE). All results were
presented as the mean standard error of the mean (SEM),
and were compared with two-way analysis of variance (ANOVA)
followed by Bonferroni’s multiple comparison test.RESULTS
With the 1H quadrature surface coil (diameter, 17mm), images
acquired with the fast spin-echo sequence showed sufficient
coverage of the rat brain, even the ventral part (Fig. 1), to allow
volume positioning in MO. The typical linewidth of the water
resonance was 10–12Hz for CO, HI and ST, and 15–17Hz for MO.
In vivo proton MR spectra of MO in rat brain were obtained with
an SNR (measured for the NAA singlet before applying
apodisation, 800–960 averages) of 16 2 (n¼ 6). Compared
with the spectra of CO, ST and HI, the spectrum of MO showed a
significant reduction in Tau resonances at 3.42 and 3.25 ppm, as
well as of Glu and Gln resonances (Fig. 1). In addition, the peak of
Ins at approximately 3.55 ppm was unusually high. Using the
basis set that did not contain the Gly resonance led to a
substantial fitted residual and slight distortion of baseline at
3.55 ppm in the LCModel analysis of in vivo NMR spectra obtained
from MO (Fig. 2), which indicates the contribution of Gly with a
resonance peak at 3.55 ppm. Adding the Gly spectrum to the
basis set, this fitted residual was reduced to noise level and the
baseline became smooth. The concentration of Gly washt  2010 John Wiley & Sons, Ltd. NMR Biomed. 2010; 23: 1097–1102
Figure 1. Representative in vivo 1H NMR spectra acquired with the spin-echo, full-intensity acquired localised (SPECIAL) sequence at 9.4 T from the
volumes of interest (VOIs) located in the medulla oblongata, cortex, hippocampus and striatum [TE¼ 2.8 ms, TR¼ 4 s, number of transients
(NT)¼ 240–800]. Fourier transform and Gaussian function weighting (exp[–(t – 0.03)2/0.122]) were applied. No baseline correction or water signal
removal was applied. See text for abbreviations.
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1quantified at 2.9 0.2 mmol/g (n¼ 6) with CRLB of 5.3 0.1%
(Fig. 3a).
A neurochemical profile of 15 metabolites including Asp, Cr,
PCr, GABA, Gln, Glu, Ins, Lac, NAA, Tau, Glc, NAAG, PE, Gly and
GPCþ PCho, was quantified in MO at TE¼ 2.8 ms with CRLBs
lower than 25% (Fig. 3b). In addition, Gly was measured in CO, HI
and ST at TE¼ 20 ms, with CRLBs below 25%, and its
concentration was 0.92 0.04 mmol/g (n¼ 6), 1.04 0.15
mmol/g (n¼ 5) and 0.95 0.08 mmol/g (n¼ 6), respectively.
These values were, on average, three-fold lower than that in MO
(p< 0.001, n¼ 6) (Fig. 3a). Other marked differences were noted
in the neurochemical profile of MO compared with the other
three brain regions: significantly lower (p< 0.001, n¼ 6)
concentrations of Glu (–50 4%), Gln (–54 3%) and Tau
(–78 3%) as averaged from CO, HI and ST, respectively.
Concentrations of PE were lower in MO, reaching half of the
concentration observed in HI (–49 7%, p< 0.01, n¼ 6) and ST
(–53 6%, p< 0.01, n¼ 6). The levels of Cr in MO tended to be
lower than in the other regions. For instance, compared with HI,
the concentration of Cr in MO was 42 2% lower (p< 0.001,
n¼ 6). The concentration of NAA in MO was similar to that in ST,NMR Biomed. 2010; 23: 1097–1102 Copyright  2010 John Wilebut lower than that in CO (–24 4%, p< 0.001, n¼ 6) and HI
(–27 4%, p< 0.001, n¼ 6).DISCUSSION
This study demonstrated the feasibility of using in vivo 1H NMR
spectroscopy to determine the neurochemical profile in rat
MO, composed of 15 metabolites including Gly, the content of
which may reflect the high density of glycinergic neurons (19).
The low CRLBs of these metabolites (below 25%) indicate
the high reliability of the current measurement. This can be
ascribed to the high SNR and spectral resolution at 9.4 T,
the use of a large quadrature surface coil that covers the
ventral part of the rat brain, and the sensitivity improvement
using an advanced localised spectroscopic technique at
short TE. Water suppression and outer volume suppression
sufficiently suppressed unwanted signals, such as lipid
signals and large water signals, which were not observed in
the spectra of MO despite the location at the brainstem (Fig. 1).
An excellent agreement of the concentrations of Glu, Gln,y & Sons, Ltd. View this article online at wileyonlinelibrary.com
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Figure 2. LCModel analysis of in vivo spectrum of the rat medulla
oblongata (data from the same rat as shown in Fig. 1, no apodisation
was applied) using the basis set without (a) and with (b) glycine (Gly). The
corresponding fit, macromolecule baseline, baseline and residual are
shown.
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0GABA and Tau in MO was found with previously quantified
values in tissue extracts (20).
The measurement in MO using the surface coil was more
challenging than that in other brain regions because of its deep
location in the posterior part of the brain. However, the SNR
obtained was still sufficient for the quantification of 15
metabolites of the neurochemical profile, which can be ascribed
to the use of the short TE and high magnetic field. After first- and
second-order shimming adjustment, the linewidth of the water
signal was 15–17Hz in MO, which was approximately 5 Hz greater
than that in the other regions; this was attributed mainly to theView this article online at wileyonlinelibrary.com Copyrigincreased magnetic field inhomogeneity because of suscepti-
bility effects induced by the nearby sinuses.
Gly was also measured in vivo in MO at TE¼ 2.8 ms with a high
precision, as judged from the low CRLB of 5% (Fig. 3). The
concentration of Gly in MO measured in this study is in the range
of previous reports using biochemical assays (20), and is
somewhat lower than the value published by Aprison et al.
(21), possibly as a result of the age difference of the rats (22).
Recently, threonine, which has one doublet close to the Gly
resonance peak at 3.55 ppm, was quantified in vivo in rat brain
(23) and human brain (24). Additional LCModel analysis using the
basis set including threonine was performed to investigate
the effect on the assessment of Gly (data not shown). However,
the resonance peaks of threonine and Lac at 1.32 ppm are
undistinguishable for LCModel, which tends to assign the
whole peak to threonine, leading to strong overestimation of
threonine and underestimation of Lac concentration. Con-
sequently, the Gly concentration would also be systematically
underestimated. The overestimated concentration of threonine
was between 1.1 and 2.6mM, which leads to a 9–21% alteration
in Gly level. As the concentration of threonine should be
0.6 0.2mM (23), its effect on the quantification of Gly is
expected to be less than 9%.
In CO, ST and HI, Gly cannot be reliably quantified at TE¼ 2.8
ms because of its lower regional concentration (approximately
1mM) and the overlap with the strong resonances of Ins.
Therefore, the measurement of the Gly concentration in CO, HI
and ST was performed at TE¼ 20 ms, where the signal
contribution from Ins wasminimised as described previously (10).
When assessing the level of Gly from the spectra acquired at
TE¼ 20 ms, T2 relaxation of Gly was assumed to be similar to that
of tCr. According to previously published T2 values of metabolites
at 9.4 T (18), T2 of singlets ranged from 113 ms (tCr) to 202 ms
(NAA). Even when assuming that T2 of Gly is close to the
longest T2, i.e. that of NAA, the Gly concentration in these three
regions (i.e. CO, ST and HI) would be 8% lower than the values
calculated using the assumption of a similar T2 to tCr, which is a
quantitatively unimportant difference.
Relative to CO, ST and HI, Gly in MO showed a three-fold higher
concentration (Fig. 3a), which is in accordancewith the reportedGly
regional distribution in rat brain (20,22). The high concentration of
Gly in MO is consistent with its neurotransmitter function in this
region. Gly has a dual role as a co-agonist for excitatory
glutamatergic neurotransmission, by binding N-methyl-D-aspartate
receptors, and as an inhibitory neurotransmitter, by activating
strychnine-sensitive Gly receptors, which are particularly concen-
trated in MO (1). Defects in glycinergic neurotransmission may
result, for example, in motor disorders, such as that observed in
hyperekplexia (25), pain perception (26) or idiopathic generalised
epilepsies (27). Thus, the concentration of Gly may eventually
become a marker of these pathological conditions.
Among the differences in the neurochemical profile of MO
compared with that of the other regions, some are of particular
interest, as they may be related to the function of Gly, e.g. the Tau
concentration in MO was particularly low. In the central nervous
system, Tau not only has an important osmoregulatory function,
but is also a modulator of Gly and GABA receptors (28). As an
agonist of glycinergic and GABAergic neurotransmission systems,
which are abundant in MO, the Tau concentration is likely to be
tightly regulated. Interestingly, the other osmolyte, Ins, was found
in MO at similar concentrations to that in other regions, namely
CO and ST. Another marked characteristic of MO was the lowht  2010 John Wiley & Sons, Ltd. NMR Biomed. 2010; 23: 1097–1102
Figure 3. Glycine (a) and other metabolite (b) concentrations and the corresponding Crame´r–Rao lower bounds (CRLBs) given by LCModel in the cortex,
hippocampus, striatum and medulla oblongata (MO). Data shown as the mean SEM of six different rats. The asterisk indicates the concentrations of
metabolites in MO that are significantly different from those in the other three regions (p< 0.001, two-way ANOVA followed by Bonferroni’s multiple
comparison test). See text for abbreviations.
GLYCINE AND NEUROCHEMICAL PROFILE IN RAT MEDULLA OBLONGATAconcentrations of Glu and Gln when compared with those in
other regions (Fig. 3b), being closely related to the prominence of
inhibitory systems in MO, and thus perhaps reflecting a lower
density of excitatory glutamatergic neurons.
Recently, the volume of MO measured by MRI has been
suggested to correlate with the degree of dysfunction in multiple
sclerosis, which is a neurodegenerative disorder leading to
atrophy of the brain and spinal cord and resulting in motor
impairment (5). Hence, the direct monitoring of the neuro-
chemical profile of MO by in vivo 1H NMR spectroscopy may thus
provide a complementary investigation of multiple sclerosi-
s-associated neurodegeneration affecting this brain area.
A few MRS studies, performed in human MO at 1.5 or 3 T
(29–31), have reported exclusively the measurement of three
major metabolites, i.e. tCr, NAA and total choline, because of the
inferior spectral quality caused by susceptibility effects from
the surrounding environment, the low SNR and spectral
resolution at low magnetic field strength, and signal loss caused
by spectroscopic methods performed at long TE. With an increase
in the magnetic field strength, such as at 7 T, the spectral
resolution and SNR can be improved, allowing the assessment of
a larger number of metabolites in human MO.1CONCLUSION
We conclude that a neurochemical profile composed of 15
metabolites, including Gly, can be reliably quantified in rat MO byNMR Biomed. 2010; 23: 1097–1102 Copyright  2010 John Wilein vivo 1H NMR spectroscopy at TE¼ 2.8 ms at 9.4 T. The ability to
measure the neurochemical profile may be useful to investigate
MO dysfunction, such as motor impairment in multiple sclerosis.
We further conclude that the functional specialisation of distinct
brain regions is reflected by specific patterns of metabolite
concentrations.Acknowledgements
This work was supported by the Centre d’Imagerie BioMe´dicale
(CIBM) of University of Lausanne (UNIL), University of Geneva
(UNIGE), Hoˆpitaux Universitaires de Gene`ve (HUG), Centre Hos-
pitalier Universitaire Vaudois (CHUV) and Ecole Polytechnique
Federale de Lausanne (EPFL), and the Leenaards and Jeantet
Foundations.REFERENCES
1. Betz H, Laube B. Glycine receptors: recent insights into their structural
organization and functional diversity. J Neurochem. 2006; 97(6):
1600–1610.
2. Fagundes LD, Rotta LN, Schweigert ID, Valle SC, de Oliveira KR, Kruger
AH, Souza KB, Souza DO, Perry MLS. Glycine, serine, and leucine
metabolism in different regions of rat central nervous system. Neuro-
chem Res. 2001; 26(3): 245–249.
3. Saransaari P, Oja SS. Mechanisms of glycine release in mouse brain
stem slices. Neurochem Res. 2009; 34(2): 286–294.y & Sons, Ltd. View this article online at wileyonlinelibrary.com
1
0
1
L. XIN ET AL.
1
1
0
24. Colombari E, SatoMA, Cravo SL, Bergamaschi CT, Campos RR Jr, Lopes
OU. Role of the medulla oblongata in hypertension. Hypertension.
2001; 38(3 Pt 2): 549–554.
5. Liptak Z, Berger AM, Sampat MP, Charil A, Felsovalyi O, Healy BC,
Hildenbrand P, Khoury SJ, Weiner HL, Bakshi R, Guttmann CR. Medulla
oblongata volume: a biomarker of spinal cord damage and disability
in multiple sclerosis. Am J Neuroradiol. 2008; 29(8): 1465–1470.
6. Pfeuffer J, Tkac I, Provencher SW, Gruetter R. Toward an in vivo
neurochemical profile: quantification of 18 metabolites in short-
echo-time (1)H NMR spectra of the rat brain. J Magn Reson. 1999;
141(1): 104–120.
7. Tkac I, Rao R, Georgieff MK, Gruetter R. Developmental and regional
changes in the neurochemical profile of the rat brain determined by
in vivo H-1 NMR spectroscopy. Magn Reson Med. 2003; 50(1): 24–32.
8. Choi C, Bhardwaj PP, Seres P, Kalra S, Tibbo PG, Coupland NJ.
Measurement of glycine in human brain by triple refocusing
1H-MRS in vivo at 3.0T. Magn Reson Med. 2008; 59(1): 59–64.
9. Gambarota G, Mekle R, Xin L, Hergt M, van der Zwaag W, Krueger G,
Gruetter R. In vivo measurement of glycine with short echo-time 1H
MRS in human brain at 7 T. Magma. 2009; 22(1): 1–4.
10. Gambarota G, Xin L, Perazzolo C, Kohler I, Mlynarik V, Gruetter R.
In vivo 1H NMR measurement of glycine in rat brain at 9.4 T at short
echo time. Magn Reson Med. 2008; 60(3): 727–731.
11. Gruetter R, Tkac I. Field mapping without reference scan using asym-
metric echo-planar techniques. Magn ResonMed. 2000; 43(2): 319–323.
12. Mlynarik V, Gambarota G, Frenkel H, Gruetter R. Localized short-
echo-time proton MR spectroscopy with full signal-intensity acqui-
sition. Magn Reson Med. 2006; 56(5): 965–970.
13. Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spectroscopy of
rat brain at 1 ms echo time. Magn Reson Med. 1999; 41(4): 649–
656.
14. Provencher SW. Estimation ofmetabolite concentrations from localized
in vivo proton NMR spectra. Magn Reson Med. 1993; 30(6): 672–679.
15. Mlynarik V, Cudalbu C, Xin L, Gruetter R. 1H NMR spectroscopy of rat
brain in vivo at 14.1 Tesla: improvements in quantification of the
neurochemical profile. J Magn Reson. 2008; 194(2): 163–168.
16. Snyder J, Thompson RB, Wild JM, Wilman AH. Strongly coupled versus
uncoupled spin response to radio frequency interference effects:
application to glutamate and glutamine in spectroscopic imaging.
NMR Biomed. 2008; 21(4): 402–409.
17. Schwab M, Bauer R, Zwiener U. The distribution of normal brain water
content in Wistar rats and its increase due to ischemia. Brain Res.
1997; 749(1): 82–87.
18. Xin L, Gambarota G, Mlynarik V, Gruetter R. Proton T2 relaxation time
of J-coupled cerebral metabolites in rat brain at 9.4 T. NMR Biomed.
2008; 21(4): 396–401.View this article online at wileyonlinelibrary.com Copyrig19. Stornetta RL, McQuiston TJ, Guyenet PG. GABAergic and glycinergic
presympathetic neurons of rat medulla oblongata identified by
retrograde transport of pseudorabies virus and in situ hybridization.
J Comp Neurol. 2004; 479(3): 257–270.
20. Suda M, Honma T, Miyagawa M, Wang RS. Alteration of brain levels of
neurotransmitters and amino acids in male F344 rats induced by
three-week repeated inhalation exposure to 1-bromopropane. Ind
Health. 2008; 46(4): 348–359.
21. Aprison MH, Shank RP, Davidoff RA. A comparison of the concen-
tration of glycine, a transmitter suspect, in different areas of the brain
and spinal cord in seven different vertebrates. Comp Biochem Physiol.
1969; 28(3): 1345–1355.
22. Cutler RW, Dudzinski DS. Regional changes in amino acid content in
developing rat brain. J Neurochem. 1974; 23(5): 1005–1009.
23. Marjanska M, Henry PG, Ugurbil K, Gruetter R. Editing through
multiple bonds: threonine detection. Magn Reson Med. 2008;
59(2): 245–251.
24. Choi C, Coupland NJ, Kalra S, Bhardwaj PP, Malykhin N, Allen PS.
Proton spectral editing for discrimination of lactate and threonine
1.31ppm resonances in human brain in vivo. Magn Reson Med. 2006;
56(3): 660–665.
25. Shiang R, Ryan SG, Zhu YZ, Hahn AF, Oconnell P, Wasmuth JJ.
Mutations in the alpha-1 subunit of the inhibitory glycine receptor
cause the dominant neurologic disorder, hyperekplexia. Nat Genet.
1993; 5(4): 351–358.
26. Ahmadi S, Lippross S, Neuhuber WL, Zeilhofer HU. PGE(2) selectively
blocks inhibitory glycinergic neurotransmission onto rat superficial
dorsal horn neurons. Nat Neurosci. 2002; 5(1): 34–40.
27. Sobetzko D, Sander T, Becker CM. Genetic variation of the human
glycine receptor subunit genes GLRA3 and GLRB and susceptibility to
idiopathic generalized epilepsies. Am J Med Genet. 2001; 105(6):
534–538.
28. Albrecht J, Schousboe A. Taurine interaction with neurotransmitter
receptors in the CNS: an update. Neurochem Res. 2005; 30(12):
1615–1621.
29. Galanaud D, Le Fur Y, Nicoli F, Denis B, Confort-Gouny S, Ranjeva JP,
Viout P, Pelletier J, Cozzone PJ. Regional metabolite levels of the
normal posterior fossa studied by proton chemical shift imaging.
Magma. 2001; 13(2): 127–133.
30. Mascalchi M, Brugnoli R, Guerrini L, Belli G, Nistri M, Politi LS, Gavazzi C,
Lolli F, Argenti G, Villari N. Single-voxel long TE 1H-MR spectroscopy of
the normal brainstem and cerebellum. J Magn Reson Imaging. 2002;
16(5): 532–537.
31. Edden RA, Bonekamp D, Smith MA, Dubey P, Barker PB, Proton MR
spectroscopic imaging of themedulla and cervical spinal cord. J Magn
Reson Imaging. 2007; 26(4): 1101–1105.ht  2010 John Wiley & Sons, Ltd. NMR Biomed. 2010; 23: 1097–1102
